YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
02 09 2019
Historique:
received: 08 01 2019
accepted: 07 08 2019
entrez: 4 9 2019
pubmed: 4 9 2019
medline: 31 12 2019
Statut: epublish

Résumé

YAP1 fusion-positive supratentorial ependymomas predominantly occur in infants, but the molecular mechanisms of oncogenesis are unknown. Here we show YAP1-MAMLD1 fusions are sufficient to drive malignant transformation in mice, and the resulting tumors share histo-molecular characteristics of human ependymomas. Nuclear localization of YAP1-MAMLD1 protein is mediated by MAMLD1 and independent of YAP1-Ser127 phosphorylation. Chromatin immunoprecipitation-sequencing analyses of human YAP1-MAMLD1-positive ependymoma reveal enrichment of NFI and TEAD transcription factor binding site motifs in YAP1-bound regulatory elements, suggesting a role for these transcription factors in YAP1-MAMLD1-driven tumorigenesis. Mutation of the TEAD binding site in the YAP1 fusion or repression of NFI targets prevents tumor induction in mice. Together, these results demonstrate that the YAP1-MAMLD1 fusion functions as an oncogenic driver of ependymoma through recruitment of TEADs and NFIs, indicating a rationale for preclinical studies to block the interaction between YAP1 fusions and NFI and TEAD transcription factors.

Identifiants

pubmed: 31477715
doi: 10.1038/s41467-019-11884-5
pii: 10.1038/s41467-019-11884-5
pmc: PMC6718408
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
DNA-Binding Proteins 0
MAMLD1 protein, human 0
NFI Transcription Factors 0
Nuclear Proteins 0
Oncogene Proteins, Fusion 0
Phosphoproteins 0
Transcription Factors 0
YAP-Signaling Proteins 0
YAP1 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3914

Subventions

Organisme : NCI NIH HHS
ID : K22 CA190440
Pays : United States

Références

Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Nat Med. 2018 Oct;24(10):1599-1610
pubmed: 30224758
Genes Dev. 2007 Apr 15;21(8):886-97
pubmed: 17437995
Acta Neuropathol. 2017 Jan;133(1):5-12
pubmed: 27858204
Cancer Cell. 2015 May 11;27(5):728-43
pubmed: 25965575
Nature. 2018 Mar 22;555(7697):469-474
pubmed: 29539639
Genes Dev. 2007 Nov 1;21(21):2747-61
pubmed: 17974916
BMC Bioinformatics. 2019 Jan 31;20(1):60
pubmed: 30704404
J Neurosurg. 2009 Apr;110(4):725-9
pubmed: 19061350
J Neurosci Methods. 2012 Jun 15;207(2):172-80
pubmed: 22521325
Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10171-6
pubmed: 19520826
PLoS One. 2012;7(3):e32783
pubmed: 22396793
Neuron. 1998 Nov;21(5):1031-44
pubmed: 9856459
Nat Cell Biol. 2015 Sep;17(9):1218-27
pubmed: 26258633
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Stem Cell Reports. 2015 May 12;4(5):795-810
pubmed: 25921811
Sci Rep. 2015 May 29;5:10668
pubmed: 26021864
Cell. 2012 Aug 17;150(4):780-91
pubmed: 22863277
Cancer Cell. 2005 Oct;8(4):323-35
pubmed: 16226707
J Neurosci. 2005 Jan 5;25(1):10-8
pubmed: 15634762
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
J Biochem. 2011 Apr;149(4):361-79
pubmed: 21324984
Genes Dev. 2013 Feb 15;27(4):355-71
pubmed: 23431053
Bioinformatics. 2016 Jan 15;32(2):292-4
pubmed: 26428292
Cell Rep. 2018 Jun 26;23(13):3787-3797
pubmed: 29949764
Onco Targets Ther. 2016 Aug 29;9:5371-81
pubmed: 27621651
Oncogene. 2017 Sep 14;36(37):5231-5242
pubmed: 28504719
Genes Dev. 2010 May;24(9):862-74
pubmed: 20439427
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Mol Cell. 2015 Oct 15;60(2):328-37
pubmed: 26439301
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):16-22
pubmed: 14603031
Nat Commun. 2017 Mar 20;8:14758
pubmed: 28317875
Nat Rev Cancer. 2015 Feb;15(2):73-79
pubmed: 25592648
Nucleic Acids Res. 2016 Jan 4;44(D1):D110-5
pubmed: 26531826
Cell. 2007 Sep 21;130(6):1120-33
pubmed: 17889654
PLoS One. 2011;6(7):e21800
pubmed: 21789182
J Biochem. 2011 Aug;150(2):199-208
pubmed: 21586534
PLoS Genet. 2015 Aug 21;11(8):e1005465
pubmed: 26295846
Nat Med. 2016 Nov;22(11):1314-1320
pubmed: 27748748
Protein Cell. 2015 Jan;6(1):6-11
pubmed: 25482410
Onco Targets Ther. 2016 May 26;9:3137-46
pubmed: 27307755
EMBO Rep. 2014 Apr;15(4):351-64
pubmed: 24639559
Cell. 2011 Mar 4;144(5):782-95
pubmed: 21376238
Genes Dev. 2008 Jul 15;22(14):1962-71
pubmed: 18579750
Genome Biol. 2008;9(9):R137
pubmed: 18798982
J Neurosci. 2010 Jul 7;30(27):9127-39
pubmed: 20610746
Genes Dev. 2009 Dec 1;23(23):2729-41
pubmed: 19952108
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Nature. 2014 Feb 27;506(7489):451-5
pubmed: 24553141
Dev Biol. 2007 May 15;305(2):616-24
pubmed: 17362912
J Clin Oncol. 2017 Jul 20;35(21):2364-2369
pubmed: 28640697
J Neurosci. 2005 Jan 5;25(1):247-51
pubmed: 15634788
Cancer Cell. 2008 Mar;13(3):188-92
pubmed: 18328423
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nature. 2016 Feb 4;530(7588):57-62
pubmed: 26814967
Oncogene. 2019 Jan;38(1):120-139
pubmed: 30082911
Semin Cell Dev Biol. 2012 Sep;23(7):785-93
pubmed: 22659496
Brain Pathol. 2019 May;29(3):325-335
pubmed: 30325077
EMBO J. 1999 May 4;18(9):2551-62
pubmed: 10228168
Genes Dev. 2012 Jun 15;26(12):1300-5
pubmed: 22677547
Oncotarget. 2016 Sep 20;7(38):61860-61873
pubmed: 27556362
Childs Nerv Syst. 2009 Nov;25(11):1383-4; author reply 1385
pubmed: 19562351
J Biol Chem. 2008 Feb 29;283(9):5525-32
pubmed: 18162467
Nat Commun. 2017 Dec 21;8(1):2244
pubmed: 29269835
Nature. 2018 Jan 4;553(7686):101-105
pubmed: 29258295
J Vis Exp. 2018 Jun 9;(136):
pubmed: 29939173
Mol Cell Biol. 2003 Dec;23(24):9014-24
pubmed: 14645514
Cancer Cell. 2014 Aug 11;26(2):273-87
pubmed: 25087979
Genes Dev. 2013 Aug 15;27(16):1769-86
pubmed: 23964093
Curr Biol. 2007 Dec 4;17(23):2054-60
pubmed: 17980593
Lancet Oncol. 2009 Mar;10(3):258-66
pubmed: 19274783
Oncotarget. 2016 Dec 6;7(49):81062-81076
pubmed: 27835600
Nat Commun. 2015 Jun 11;6:7391
pubmed: 26067104
Nat Rev Cancer. 2013 Apr;13(4):246-57
pubmed: 23467301
Brain Pathol. 2019 Mar;29(2):205-216
pubmed: 30246434
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
PLoS One. 2016 Dec 1;11(12):e0167417
pubmed: 27907167
J Surg Res. 2009 Oct;156(2):340-51
pubmed: 19577759

Auteurs

Kristian W Pajtler (KW)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, 69120, Heidelberg, Germany.

Yiju Wei (Y)

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Penn State Health Hershey Medical Center, Penn State College of Medicine, Hershey, PA, 17033, USA.

Konstantin Okonechnikov (K)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Patricia B G Silva (PBG)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Mikaella Vouri (M)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Lei Zhang (L)

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Penn State Health Hershey Medical Center, Penn State College of Medicine, Hershey, PA, 17033, USA.

Sebastian Brabetz (S)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Laura Sieber (L)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Melissa Gulley (M)

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Penn State Health Hershey Medical Center, Penn State College of Medicine, Hershey, PA, 17033, USA.

Monika Mauermann (M)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Tatjana Wedig (T)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Norman Mack (N)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Yuka Imamura Kawasawa (Y)

Department of Biochemistry and Molecular Biology, Penn State Health Hershey Medical Center, Penn State College of Medicine, Hershey, PA, 17033, USA.
Department of Pharmacology, Penn State Health Hershey Medical Center, Penn State College of Medicine, Hershey, PA, 17033, USA.

Tanvi Sharma (T)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Marc Zuckermann (M)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Felipe Andreiuolo (F)

Department of Neuropathology, Ste. Anne Hospital, 75014, Paris, France.

Eric Holland (E)

Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.

Kendra Maass (K)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Huiqin Körkel-Qu (H)

Division of Molecular Neurogenetics, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Hai-Kun Liu (HK)

Division of Molecular Neurogenetics, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Felix Sahm (F)

Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Department of Neuropathology, Heidelberg University Hospital, 69120, Heidelberg, Germany.

David Capper (D)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Neuropathology, Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Jens Bunt (J)

Queensland Brain Institute, The University of Queensland, Brisbane, 4072, Australia.

Linda J Richards (LJ)

Queensland Brain Institute, The University of Queensland, Brisbane, 4072, Australia.

David T W Jones (DTW)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Andrey Korshunov (A)

Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Department of Neuropathology, Heidelberg University Hospital, 69120, Heidelberg, Germany.

Lukas Chavez (L)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Peter Lichter (P)

Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Mikio Hoshino (M)

Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, Tokyo, Japan.

Stefan M Pfister (SM)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, 69120, Heidelberg, Germany.

Marcel Kool (M)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.

Wei Li (W)

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Penn State Health Hershey Medical Center, Penn State College of Medicine, Hershey, PA, 17033, USA. weili@pennstatehealth.psu.edu.
Department of Biochemistry and Molecular Biology, Penn State Health Hershey Medical Center, Penn State College of Medicine, Hershey, PA, 17033, USA. weili@pennstatehealth.psu.edu.

Daisuke Kawauchi (D)

Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany. d.kawauchi@kitz-heidelberg.de.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. d.kawauchi@kitz-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH